VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
VYNE Therapeutics reports 2022 executive compensation
By ExecPay News
Published: November 13, 2023
VYNE Therapeutics reported fiscal year 2022 executive compensation information on November 13, 2023.
In 2022, three executives at VYNE Therapeutics received on average a compensation package of $867K, a 65% decrease compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
David Domzalski, Chief Executive Officer, received $1.3M in total, which decreased by 73% compared to 2021. 49% of Domzalski's compensation, or $638K, was in salary. Domzalski also received $325K in non-equity incentive plan, $128K in option awards, $191K in stock awards, as well as $12K in other compensation.
Mutya Harsch, Chief Legal Officer, received a compensation package of $654K, which decreased by 50% compared to previous year. 65% of the compensation package, or $422K, was in salary.
Iain Stuart, Chief Scientific Officer, earned $654K in 2022, a 49% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on November 13, 2023.